Premium
Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services
Author(s) -
Jean J.P.,
Abbs I.,
Calman F.,
Gleeson M.,
Lyons A.,
Hussain K.,
McGurk M.,
O’Connell M.,
Probert D.,
Ng R.,
Simo R.
Publication year - 2008
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/j.1749-4486.2008.01637.x
Subject(s) - medicine , head and neck cancer , excellence , nice , head and neck , cancer , surgery , political science , computer science , law , programming language
Keypoints• The implementation of the National Institute of Clinical Excellence improving outcome guidelines (NICE‐IOG) manual for head and neck cancer may have a huge potential cost implication. • Head and neck cancer is a rare disease which utilises large quantities of resources which can only be provided in a tertiary centre. • Head and neck cancer services should be centralised into a single site for each cancer network. • A new higher tariff rate for complex head and neck cancer cases is needed which recognises the true cost of this work. • Each network should set its own tariff to make head and neck cancer care financially viable.